CurrentRheuma
Get Weekly

Topic · page 9 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 321–360 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. RMD Open

    Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients

    Cohort study

  2. Semin Arthritis Rheum

    High prevalence and incidence of systemic sclerosis in Reunion Island, a French multi-ethnical and tropical territory

    Cohort study

  3. RMD Open

    Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile

    Case-control study

  4. Clin Exp Rheumatol

    Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patients

    Cross-sectional study

  5. Lancet Rheumatol

    CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series

    Cohort study

  6. Clin Exp Rheumatol

    Evaluation of the Coping Strategies Questionnaire-Revised for fatigue in systemic sclerosis: a Scleroderma Patient-centred Intervention Network (SPIN) cohort study

    Cohort study

  7. Arthritis Care Res (Hoboken)

    Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort

    Cohort study

  8. Lancet Rheumatol

    Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study

    Cohort study

  9. Arthritis Res Ther

    Brain functional alternation in patients with systemic sclerosis: a resting-state functional magnetic resonance imaging study

    Cross-sectional study

  10. Clin Exp Rheumatol

    ADAMTS13 and insulin resistance in systemic sclerosis patients

    Cross-sectional study

  11. Rheumatology (Oxford)

    Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis

    Cohort study

  12. Arthritis Res Ther

    Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis

    Cohort study

  13. Rheumatology (Oxford)

    Combined radiographic and US evaluations to decipher joint involvement in the hands of patients with SSc

    Cross-sectional study

  14. Rheumatology (Oxford)

    Healthcare utilization in general practice and hospitals preceding a diagnosis of systemic sclerosis: a nationwide registry study

    Cohort study

  15. Clin Exp Rheumatol

    Clinical characteristics and clinical risk model of the lower gastrointestinal involvement in systemic sclerosis

    Case-control study

  16. Rheumatology (Oxford)

    Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participants

    Cross-sectional study

  17. Clin Exp Rheumatol

    Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis

    Cross-sectional study

  18. Ann Rheum Dis

    Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis

    Mechanistic study

  19. Arthritis Res Ther

    Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents

    Cohort study

  20. Ann Rheum Dis

    Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures

    Cross-sectional study

  21. Ann Rheum Dis

    Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

    Cohort study

  22. RMD Open

    Comorbidity burden on mortality in patients with systemic sclerosis

    Cohort study

  23. Rheumatology (Oxford)

    Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival

    Cohort study

  24. Rheumatology (Oxford)

    FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease

    Cross-sectional study

  25. Rheumatology (Oxford)

    Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL

    Diagnostic or prognostic study

  26. Rheumatology (Oxford)

    Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis

    Cross-sectional study

  27. Rheumatology (Oxford)

    Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women—a case–control study

    Research article

  28. Arthritis Care Res (Hoboken)

    Comparison of Three Physician Global Assessment Instruments in Systemic Sclerosis

    Cohort study

  29. Rheumatology (Oxford)

    Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis

    Cross-sectional study

  30. Arthritis Care Res (Hoboken)

    Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort

    Cohort study

  31. Rheumatology (Oxford)

    Digital ulcers in systemic sclerosis are strongly associated with digital arterial disease: a finger-by-finger analysis of finger brachial pressure index measurements

    Cross-sectional study

  32. Rheumatology (Oxford)

    Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life

    Cohort study

  33. Arthritis Rheumatol

    Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement

    Mechanistic study

  34. Rheumatology (Oxford)

    Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease

    Cross-sectional study

  35. Rheumatology (Oxford)

    Colour changes in the feet: a sign of autonomic symptoms in systemic sclerosis

    Cross-sectional study

  36. RMD Open

    Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis

    Cohort study

  37. Rheumatology (Oxford)

    Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis

    Cohort study

  38. Arthritis Rheumatol

    Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis

    Mechanistic study

  39. Semin Arthritis Rheum

    Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH)

    Cross-sectional study

  40. Rheumatology (Oxford)

    The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary

    Guideline or statement

All 671 Briefs in ExploreShowing Briefs 321–360 of 671, newest first